Role of glycine N-methyltransferase in experimental ulcerative colitis

Wen Yueh Chou, Jin Feng Zhao, Yi Ming Arthur Chen, Kuan I. Lee, Kuo Hui Su, Song Kun Shyue, Tzong Shyuan Lee

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background and Aim: Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders with unclear etiology and mechanism(s). Glycine N-methyltransferase (GNMT) plays a central role in inflammatory diseases such as hepatitis and atherosclerosis. However, little is known about the impact of GNMT and the involved mechanism in the pathogenesis of IBD. In the current study, we investigated the role of GNMT in the mouse model of dextran sulfate sodium (DSS)-induced colitis. Methods: Protein expression was determined by Western blotting or immunohistochemistry. Histopathology was examined by hematoxylin and eosin staining. Levels of pro-inflammatory cytokines were evaluated by ELISA kits. Results: GNMT was expressed in the epithelium of the colon under normal conditions, and with DSS treatment, its expression was predominant in infiltrated leukocytes of lesions. Mice with genetic deletion of GNMT (GNMT-/-) showed increased susceptibility to DSS induction of colitis, as revealed by the progression of colitis. Additionally, severe colonic inflammation, including increased crypt loss, leukocyte infiltration, and hemorrhage, was greater with DSS treatment in GNMT-/- than wild-type mice. Furthermore, the expression of adhesion molecule and inflammatory mediators in the colon was significantly higher with DSS treatment in GNMT-/- than wild-type mice. Moreover, loss of GNMT decreased cell apoptosis in colitis lesions with DSS treatment. Conclusions: Collectively, our findings suggest that GNMT may be a crucial molecule in the pathogenesis of DSS-induced colitis. This finding may provide new information for a potential therapeutic target in treating IBD.

Original languageEnglish
Pages (from-to)494-501
Number of pages8
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume29
Issue number3
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Glycine N-Methyltransferase
Ulcerative Colitis
Dextran Sulfate
Colitis
Inflammatory Bowel Diseases
Colon
Leukocytes
Therapeutics
Hematoxylin
Eosine Yellowish-(YS)
Hepatitis
Atherosclerosis
Epithelium

Keywords

  • Colitis
  • Dextran sulfate sodium
  • GNMT
  • Inflammation

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Role of glycine N-methyltransferase in experimental ulcerative colitis. / Chou, Wen Yueh; Zhao, Jin Feng; Chen, Yi Ming Arthur; Lee, Kuan I.; Su, Kuo Hui; Shyue, Song Kun; Lee, Tzong Shyuan.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 29, No. 3, 01.01.2014, p. 494-501.

Research output: Contribution to journalArticle

Chou, Wen Yueh ; Zhao, Jin Feng ; Chen, Yi Ming Arthur ; Lee, Kuan I. ; Su, Kuo Hui ; Shyue, Song Kun ; Lee, Tzong Shyuan. / Role of glycine N-methyltransferase in experimental ulcerative colitis. In: Journal of Gastroenterology and Hepatology (Australia). 2014 ; Vol. 29, No. 3. pp. 494-501.
@article{c7421d698dc645e98abc066e95e7b82a,
title = "Role of glycine N-methyltransferase in experimental ulcerative colitis",
abstract = "Background and Aim: Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders with unclear etiology and mechanism(s). Glycine N-methyltransferase (GNMT) plays a central role in inflammatory diseases such as hepatitis and atherosclerosis. However, little is known about the impact of GNMT and the involved mechanism in the pathogenesis of IBD. In the current study, we investigated the role of GNMT in the mouse model of dextran sulfate sodium (DSS)-induced colitis. Methods: Protein expression was determined by Western blotting or immunohistochemistry. Histopathology was examined by hematoxylin and eosin staining. Levels of pro-inflammatory cytokines were evaluated by ELISA kits. Results: GNMT was expressed in the epithelium of the colon under normal conditions, and with DSS treatment, its expression was predominant in infiltrated leukocytes of lesions. Mice with genetic deletion of GNMT (GNMT-/-) showed increased susceptibility to DSS induction of colitis, as revealed by the progression of colitis. Additionally, severe colonic inflammation, including increased crypt loss, leukocyte infiltration, and hemorrhage, was greater with DSS treatment in GNMT-/- than wild-type mice. Furthermore, the expression of adhesion molecule and inflammatory mediators in the colon was significantly higher with DSS treatment in GNMT-/- than wild-type mice. Moreover, loss of GNMT decreased cell apoptosis in colitis lesions with DSS treatment. Conclusions: Collectively, our findings suggest that GNMT may be a crucial molecule in the pathogenesis of DSS-induced colitis. This finding may provide new information for a potential therapeutic target in treating IBD.",
keywords = "Colitis, Dextran sulfate sodium, GNMT, Inflammation",
author = "Chou, {Wen Yueh} and Zhao, {Jin Feng} and Chen, {Yi Ming Arthur} and Lee, {Kuan I.} and Su, {Kuo Hui} and Shyue, {Song Kun} and Lee, {Tzong Shyuan}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/jgh.12434",
language = "English",
volume = "29",
pages = "494--501",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Role of glycine N-methyltransferase in experimental ulcerative colitis

AU - Chou, Wen Yueh

AU - Zhao, Jin Feng

AU - Chen, Yi Ming Arthur

AU - Lee, Kuan I.

AU - Su, Kuo Hui

AU - Shyue, Song Kun

AU - Lee, Tzong Shyuan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background and Aim: Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders with unclear etiology and mechanism(s). Glycine N-methyltransferase (GNMT) plays a central role in inflammatory diseases such as hepatitis and atherosclerosis. However, little is known about the impact of GNMT and the involved mechanism in the pathogenesis of IBD. In the current study, we investigated the role of GNMT in the mouse model of dextran sulfate sodium (DSS)-induced colitis. Methods: Protein expression was determined by Western blotting or immunohistochemistry. Histopathology was examined by hematoxylin and eosin staining. Levels of pro-inflammatory cytokines were evaluated by ELISA kits. Results: GNMT was expressed in the epithelium of the colon under normal conditions, and with DSS treatment, its expression was predominant in infiltrated leukocytes of lesions. Mice with genetic deletion of GNMT (GNMT-/-) showed increased susceptibility to DSS induction of colitis, as revealed by the progression of colitis. Additionally, severe colonic inflammation, including increased crypt loss, leukocyte infiltration, and hemorrhage, was greater with DSS treatment in GNMT-/- than wild-type mice. Furthermore, the expression of adhesion molecule and inflammatory mediators in the colon was significantly higher with DSS treatment in GNMT-/- than wild-type mice. Moreover, loss of GNMT decreased cell apoptosis in colitis lesions with DSS treatment. Conclusions: Collectively, our findings suggest that GNMT may be a crucial molecule in the pathogenesis of DSS-induced colitis. This finding may provide new information for a potential therapeutic target in treating IBD.

AB - Background and Aim: Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders with unclear etiology and mechanism(s). Glycine N-methyltransferase (GNMT) plays a central role in inflammatory diseases such as hepatitis and atherosclerosis. However, little is known about the impact of GNMT and the involved mechanism in the pathogenesis of IBD. In the current study, we investigated the role of GNMT in the mouse model of dextran sulfate sodium (DSS)-induced colitis. Methods: Protein expression was determined by Western blotting or immunohistochemistry. Histopathology was examined by hematoxylin and eosin staining. Levels of pro-inflammatory cytokines were evaluated by ELISA kits. Results: GNMT was expressed in the epithelium of the colon under normal conditions, and with DSS treatment, its expression was predominant in infiltrated leukocytes of lesions. Mice with genetic deletion of GNMT (GNMT-/-) showed increased susceptibility to DSS induction of colitis, as revealed by the progression of colitis. Additionally, severe colonic inflammation, including increased crypt loss, leukocyte infiltration, and hemorrhage, was greater with DSS treatment in GNMT-/- than wild-type mice. Furthermore, the expression of adhesion molecule and inflammatory mediators in the colon was significantly higher with DSS treatment in GNMT-/- than wild-type mice. Moreover, loss of GNMT decreased cell apoptosis in colitis lesions with DSS treatment. Conclusions: Collectively, our findings suggest that GNMT may be a crucial molecule in the pathogenesis of DSS-induced colitis. This finding may provide new information for a potential therapeutic target in treating IBD.

KW - Colitis

KW - Dextran sulfate sodium

KW - GNMT

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84897586727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897586727&partnerID=8YFLogxK

U2 - 10.1111/jgh.12434

DO - 10.1111/jgh.12434

M3 - Article

C2 - 24219143

AN - SCOPUS:84897586727

VL - 29

SP - 494

EP - 501

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 3

ER -